Different Duration of Quadruple Therapy for First-line Helicobacter Pylori Eradication Treatment——A Randomized,Controlled Trial

Zhang Mei,Zhu Hong-ming,Cheng Hong
2010-01-01
Abstract:Objective:To compare efficacy of different duration of quadruple therapy in first-line treatment for H.pylori infection. Methods:The subjects were the patients with H.pylori infection who received endoscopy examination due to upper gastrointestinal symptoms. All patients were randomly divided into 2 groups,as follows:group LACB7,lansoprazole 30mg Bid,amoxicillin 1 000mg Bid,clarithromycin 500mg Bid,Bismuth potassium citrate 220mg Bid,for 7 days.Group LACB10:the same regimen of group LACB7 but for 10 days duration. H.pylori status was rechecked by ~(13)C-urea breath test 4 week after the end of therapy.Results:A total of 125 patients were enrolled including 60 males.The average of the patients was 48.3 years old ranged from 20 to 75 years old.H.pylori eradication rates with per protocol analyses were 82.5% and 86.2% in group LACB7 and LACB10,respectively (P>0.05).Intention to treat eradication rates were 78.3%,and 78.2% in group LACB7 and LACB10,respectively (P>0.05).Conclusion:7 days and 10 days Bismuth-based quadruple therapy for H.pylori eradication are similar in terms of efficacy,safety and patient compliance.
What problem does this paper attempt to address?